These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 28797308
1. Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! Arigliani M, Rech Morassutti F, Fabris M, Melli P, Tonutti E, Cogo P. Ital J Pediatr; 2017 Aug 10; 43(1):70. PubMed ID: 28797308 [Abstract] [Full Text] [Related]
2. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. Monzani A, Rapa A, Fonio P, Tognato E, Panigati L, Oderda G. J Pediatr Gastroenterol Nutr; 2011 Jul 10; 53(1):55-60. PubMed ID: 21694536 [Abstract] [Full Text] [Related]
3. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Mäki M. Scand J Gastroenterol; 2007 Dec 10; 42(12):1428-33. PubMed ID: 17852878 [Abstract] [Full Text] [Related]
4. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies. Sayed SK, Imam HM, Mahran AM, Refaiy AM. Egypt J Immunol; 2012 Dec 10; 19(2):41-52. PubMed ID: 23885406 [Abstract] [Full Text] [Related]
5. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease. Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I. J Clin Lab Anal; 2009 Dec 10; 23(3):165-71. PubMed ID: 19455636 [Abstract] [Full Text] [Related]
6. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Agardh D. Clin Gastroenterol Hepatol; 2007 Nov 10; 5(11):1276-81. PubMed ID: 17683995 [Abstract] [Full Text] [Related]
13. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Rashtak S, Ettore MW, Homburger HA, Murray JA. Clin Gastroenterol Hepatol; 2008 Apr 10; 6(4):426-32; quiz 370. PubMed ID: 18304884 [Abstract] [Full Text] [Related]
14. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Gatselis NK, Zachou K, Norman GL, Tzellas G, Speletas M, Gabeta S, Germenis A, Koukoulis GK, Dalekos GN. Clin Chim Acta; 2012 Oct 09; 413(19-20):1683-8. PubMed ID: 22643316 [Abstract] [Full Text] [Related]
15. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease]. Sabelnikova EA, Parfenov AI, Krums LM, Gudkova RB, Sagynbaeva VE, Bykova SV. Ter Arkh; 2014 Oct 09; 86(2):39-43. PubMed ID: 24772506 [Abstract] [Full Text] [Related]
16. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease. Prause C, Ritter M, Probst C, Daehnrich C, Schlumberger W, Komorowski L, Lieske R, Richter T, Hauer AC, Stern M, Uhlig HH, Laass MW, Zimmer KP, Mothes T. J Pediatr Gastroenterol Nutr; 2009 Jul 09; 49(1):52-8. PubMed ID: 19465869 [Abstract] [Full Text] [Related]